Literature DB >> 22722943

Outcome on hearing and facial nerve function in microsurgical treatment of small vestibular schwannoma via the middle cranial fossa approach.

Christian Ginzkey1, Matthias Scheich, Wilma Harnisch, Verena Bonn, Desiree Ehrmann-Müller, Wafaa Shehata-Dieler, Robert Mlynski, Rudolf Hagen.   

Abstract

Encouraging results regarding hearing preservation and facial nerve function as well as increasing understanding of the natural behaviour of vestibular schwannomas have led to the recommendation of an early treatment in small VS. The aim of the present study was to evaluate current data on functional outcome of patients with small VS treated by middle cranial fossa (MCF) approach. A retrospective chart study of all cases treated by MCF approach between October 2007 and September 2011 was performed. Records were analyzed regarding demographical data, tumor size, hearing status, vestibular function and facial nerve function. Facial nerve function was classified according to the House-Brackmann scale (HB). Hearing status was classified according to the American Association of Otolaryngology-Head and Neck Surgery (AAO-HNS) and a modified classification of Gardner and Robertson (GR). Eighty-nine patients were included in the study; 41 % of VS was classified as intracanalicular (stage 1) and 59 % as stage 2. From 65 patients with a preoperative hearing status according to AAO-HNS A or B, 74 % still presented with A or B after surgery. Using a modified GR classification, from 70 patients categorized as class I or II prior to surgery, 70 % were still class I or II. Looking to the facial nerve function 1 week after surgery, 82 % of patients presented with HB 1 or 2. Three to twelve months later, 96 % demonstrated HB 1 or 2. A persisting facial palsy was recorded in four patients. Preoperative hearing status was evaluated as a prognostic factor for postoperative hearing, whereas no influence was detected in ABR, vestibular function and tumor length. Early diagnosis of small VS due to high-sensitive MRI requires the management of this tumor entity. Natural behaviour of VS in many cases demonstrates an increase of tumor size over time with deterioration of hearing status. The presented data underline the recommendation of an early surgical treatment in small VS as a valuable option for hearing preservation in the therapy of VS.

Entities:  

Mesh:

Year:  2012        PMID: 22722943     DOI: 10.1007/s00405-012-2074-8

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  35 in total

1.  Small acoustic neuromas: surgical outcomes versus observation or radiation.

Authors:  Ted A Meyer; Paul A Canty; Eric P Wilkinson; Marlan R Hansen; Jay T Rubinstein; Bruce J Gantz
Journal:  Otol Neurotol       Date:  2006-04       Impact factor: 2.311

2.  The value of intraoperative facial nerve electromyography in predicting facial nerve function after vestibular schwannoma surgery.

Authors:  Michael E Sughrue; Rajwant Kaur; Ari J Kane; Martin J Rutkowski; Gurvinder Kaur; Isaac Yang; Lawrence H Pitts; Andrew T Parsa
Journal:  J Clin Neurosci       Date:  2010-05-14       Impact factor: 1.961

3.  Hearing preservation rates after microsurgical resection of vestibular schwannoma.

Authors:  Michael E Sughrue; Isaac Yang; Derick Aranda; Ari J Kane; Andrew T Parsa
Journal:  J Clin Neurosci       Date:  2010-09       Impact factor: 1.961

4.  Improved preservation of hearing and facial nerve function in vestibular schwannoma surgery via the retrosigmoid approach in a series of 200 patients.

Authors:  Madjid Samii; Venelin Gerganov; Amir Samii
Journal:  J Neurosurg       Date:  2006-10       Impact factor: 5.115

Review 5.  Management of vestibular schwannomas (acoustic neuromas): the value of neurophysiology for evaluation and prediction of auditory function in 420 cases.

Authors:  C Matthies; M Samii
Journal:  Neurosurgery       Date:  1997-05       Impact factor: 4.654

6.  The wait and see strategy for intracanalicular vestibular schwannomas.

Authors:  Pierre-Hugues Roche; Outouma Soumare; Jean-Marc Thomassin; Jean Régis
Journal:  Prog Neurol Surg       Date:  2008

Review 7.  Hearing preservation in unilateral acoustic neuroma surgery.

Authors:  G Gardner; J H Robertson
Journal:  Ann Otol Rhinol Laryngol       Date:  1988 Jan-Feb       Impact factor: 1.547

8.  Middle fossa versus retrosigmoid-transmeatal approach in vestibular schwannoma surgery: a prospective study.

Authors:  Vittorio Colletti; Francesco Fiorino
Journal:  Otol Neurotol       Date:  2003-11       Impact factor: 2.311

9.  Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). American Academy of Otolaryngology-Head and Neck Surgery Foundation, INC.

Authors: 
Journal:  Otolaryngol Head Neck Surg       Date:  1995-09       Impact factor: 3.497

10.  Cochlear implantation in the neurofibromatosis type 2 patient: long-term follow-up.

Authors:  Brian A Neff; R Mark Wiet; John M Lasak; Noel L Cohen; Harold C Pillsbury; Richard T Ramsden; D Bradley Welling
Journal:  Laryngoscope       Date:  2007-06       Impact factor: 3.325

View more
  11 in total

1.  Vestibular assessment in patients with vestibular schwannomas: what really matters?

Authors:  R Teggi; A Franzin; G Spatola; N Boari; P Picozzi; M Bailo; L O Piccioni; F Gagliardi; P Mortini; M Bussi
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-04       Impact factor: 2.124

Review 2.  Neuromonitoring of the cochlear nerve during vestibular schwannoma resection and simultaneous cochlear implantation.

Authors:  Nora M Weiss; Wilma Großmann; Sebastian P Schraven; Tobias Oberhoffner; Robert Mlynski
Journal:  HNO       Date:  2021-05-21       Impact factor: 1.284

3.  Cochlear Patency after Translabyrinthine and Retrosigmoid Vestibular Schwannoma Surgery.

Authors:  Huibert Frans van Waegeningh; Elke Loos; Tony Van Havenbergh; Thomas Somers
Journal:  J Int Adv Otol       Date:  2020-04       Impact factor: 1.017

Review 4.  [Neuromonitoring of the cochlear nerve during vestibular schwannoma resection and simultaneous cochlear implantation. German version].

Authors:  Nora M Weiss; Wilma Großmann; Sebastian Schraven; Tobias Oberhoffner; Robert Mlynski
Journal:  HNO       Date:  2021-03-17       Impact factor: 1.284

5.  [Hearing results after middle fossa removal of small (T1/T2) vestibular schwannomas].

Authors:  M Scheich; D Ehrmann-Müller; W Shehata-Dieler; R Hagen
Journal:  HNO       Date:  2017-09       Impact factor: 1.284

6.  Small Vestibular Schwannomas: Does Surgery Remain a Viable Treatment Option?

Authors:  Amjad N Anaizi; Vincent V DiNapoli; Myles Pensak; Philip V Theodosopoulos
Journal:  J Neurol Surg B Skull Base       Date:  2015-10-08

7.  Auditory Brain Stem Response Predictors of Hearing Outcomes after Middle Fossa Resection of Vestibular Schwannomas.

Authors:  Yin Ren; Catherine M Merna; Kareem O Tawfik; Marc S Schwartz; Rick A Friedman
Journal:  J Neurol Surg B Skull Base       Date:  2021-01-21

8.  Management of CSF leakage after microsurgery for vestibular schwannoma via the middle cranial fossa approach.

Authors:  Matthias Scheich; Christian Ginzkey; Desiree Ehrmann-Müller; Wafaa Shehata-Dieler; Rudolf Hagen
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-09       Impact factor: 2.503

9.  Quality of life after microsurgery for vestibular schwannoma via the middle cranial fossa approach.

Authors:  Matthias Scheich; Christian Ginzkey; Edith Reuter; Wilma Harnisch; Desiree Ehrmann; Rudolf Hagen
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-09-06       Impact factor: 2.503

10.  Outcomes after mini-craniotomy middle fossa approach combined with mastoidectomy for lateral skull base defects.

Authors:  Amit Walia; Daniel Lander; Nedim Durakovic; Matthew Shew; Cameron C Wick; Jacques Herzog
Journal:  Am J Otolaryngol       Date:  2020-10-24       Impact factor: 1.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.